State TX
Clinical Trials in Texas
Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Texas
Frequently Asked Questions — Clinical Trials in Texas
How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 736 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 736. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Texas
NCT05005403 Phase 1
Recruiting
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With N...
Condition
Non-Small Cell Lung Cancer
Enrollment
694 pts
Location
United States, Canada, Israel
Sponsor
AbbVie
NCT05336383 Phase 2
Recruiting
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Ch...
Condition
Multiple Myeloma
Enrollment
30 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT07140783 Phase 3
Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Kerato...
Condition
Vision Loss Night
Enrollment
200 pts
Location
United States
Sponsor
Ocuphire Pharma, Inc.
NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
NCT06514794 Phase 2
Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-C...
Condition
T-cell Acute Lymphoblastic Leukemia
Enrollment
125 pts
Location
United States, Australia
Sponsor
Wugen, Inc.
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
NCT06517875 Phase 2
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Trans...
Condition
Primary Myelofibrosis
Enrollment
68 pts
Location
United States, Canada, France
Sponsor
GlaxoSmithKline
NCT06858579 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic In...
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
256 pts
Location
United States, Argentina, Australia
Sponsor
Dianthus Therapeutics
NCT07359846 Phase 3
Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With...
Condition
Severe Asthma
Enrollment
786 pts
Location
United States
Sponsor
Generate Biomedicines
NCT03961945 N/A
Recruiting
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus...
Condition
Barrett Esophagus
Enrollment
1,550 pts
Location
United States
Sponsor
Mayo Clinic
NCT03424005 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in...
Condition
Metastatic Breast Cancer
Enrollment
792 pts
Location
United States, Australia, France
Sponsor
Hoffmann-La Roche
NCT06015295 N/A
Recruiting
A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT...
Condition
Brain Metastases
Enrollment
20 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT06977724 Phase 1
Recruiting
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effect...
Condition
Dry Eye Syndrome
Enrollment
36 pts
Location
United States, Netherlands
Sponsor
AbbVie
NCT06392386 Phase 2, Phase 3
Recruiting
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of ...
Condition
Generalized Myasthenia Gravis
Enrollment
12 pts
Location
United States, Belgium, Canada
Sponsor
argenx
NCT02193841 Phase 3
Recruiting
Simple Bone Cysts in Kids
Condition
Bone Cyst
Enrollment
160 pts
Location
United States, Australia, Canada
Sponsor
The Hospital for Sick Children
NCT04708054 Phase 2, Phase 3
Recruiting
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With...
Condition
Acute Myeloid Leukemia
Enrollment
324 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT07102966 N/A
Recruiting
Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas
Condition
Rare Diseases
Enrollment
410 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT04433572 Phase 3
Recruiting
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Reva...
Condition
Peripheral Artery Disease
Enrollment
250 pts
Location
United States
Sponsor
Mercator MedSystems, Inc.
NCT05871372 N/A
Recruiting
Intracranial Investigation of Neural Circuity Underlying Human Mood
Condition
Depression
Enrollment
58 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT06162221 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Condition
Non-Small Cell Lung Cancer, NSCLC
Enrollment
616 pts
Location
United States, Australia, Denmark
Sponsor
Revolution Medicines, Inc.
NCT04899947 N/A
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
Condition
Narcolepsy
Enrollment
500 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
Page 1 of 30 — 736 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology